# Sinobiopharma, Inc. — Form D

Sinobiopharma, Inc. of Nantong City, F4, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-27. The offering totals $35K, of which $35K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-08-27
- Form: D
- Accession: 0001144204-09-045841
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $35K
- Amount sold: $35K
- Minimum investment: $35K
- Investors: 1
- Date of first sale: 2009-07-14
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-133972

## Issuer

- Name: Sinobiopharma, Inc.
- CIK: 0001403612
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2006
- Address: 8 Zhong Tian Road, Nantong City, F4, 226009
- Phone: 011-86-51-385328336

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Xuejun Chen | Director | Nanjing City, F4 |
| Yuanwei Chen | Director | North Haven, CT |
| Lequn Lee Huang | Director | East Haven, CT |
| Martin Shen | Director | Singapore, U0 |
| Jianguo Wang | Director | Detroit, MI |
| Xuejun Chen | Executive Officer | Nanjing City, F4 |
| Lequn Lee Huang | Executive Officer | East Haven, CT |
| Jianguo Wang | Executive Officer | Detroit, MI |

## More

- [CIK 1403612 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1403612&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001144204-09-045841.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.